Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003687 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of Lu AG06474 in Healthy Young Men
A Phase 1 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 79
- Enrollment target
NCT05003687 is a Phase 1 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 79 participants.
The verdict
NCT05003687, a Phase 1 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the safety and tolerability of Lu AG06474 and what the body does to Lu AG06474 after swallowing single doses of the drug.
Interventions
- DRUG Placebo
- DRUG Lu AG06474
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2021-08-04 |
| Est. Completion | 2022-12-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003687
The ClinicalTrials.gov registry entry for NCT05003687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05003687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05003687 about?
NCT05003687 is a clinical study titled "Safety and Tolerability of Lu AG06474 in Healthy Young Men". The purpose of this study is to investigate the safety and tolerability of Lu AG06474 and what the body does to Lu AG06474 after swallowing single doses of the drug.
What is the current status of trial NCT05003687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 79 participants. The study started on 2021-08-04. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT05003687?
The interventions under investigation include: Placebo (DRUG), Lu AG06474 (DRUG).
Who is sponsoring clinical trial NCT05003687?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.